1. Home
  2. GDRX vs MGTX Comparison

GDRX vs MGTX Comparison

Compare GDRX & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

N/A

Current Price

$3.27

Market Cap

1.2B

Sector

Technology

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

N/A

Current Price

$10.68

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDRX
MGTX
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
GDRX
MGTX
Price
$3.27
$10.68
Analyst Decision
Hold
Buy
Analyst Count
15
8
Target Price
$4.03
★ $27.75
AVG Volume (30 Days)
767.6K
★ 815.0K
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 125.00
33.02
EPS
0.03
★ 1.30
Revenue
★ $796,853,000.00
$81,391,000.00
Revenue This Year
$0.18
$314.19
Revenue Next Year
$5.06
N/A
P/E Ratio
$109.00
★ $8.49
Revenue Growth
0.57
★ 144.57
52 Week Low
$1.77
$6.62
52 Week High
$5.61
$15.35

Technical Indicators

Market Signals
Indicator
GDRX
MGTX
Relative Strength Index (RSI) 45.50 27.75
Support Level $3.29 $8.84
Resistance Level $3.58 $11.85
Average True Range (ATR) 0.10 0.57
MACD -0.02 -0.21
Stochastic Oscillator 24.29 8.33

Price Performance

Historical Comparison
GDRX
MGTX

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: